DDW 2022: Investigational Oral Microbiome Therapy CD101 Reduces Recurrences of Clostridioides difficile Infection
Both a single dose and a second dose after recurrence were found to be safe and effective
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.